BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khan J, Bittner ML, Saal LH, Teichmann U, Azorsa DO, Gooden GC, Pavan WJ, Trent JM, Meltzer PS. cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene. Proc Natl Acad Sci USA. 1999;96:13264-13269. [PMID: 10557309 DOI: 10.1073/pnas.96.23.13264] [Cited by in Crossref: 231] [Cited by in F6Publishing: 206] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Bermejo-rodríguez C, Pérez-caro M, Pérez-mancera PA, Sánchez-beato M, Piris MA, Sánchez-garcía I. Mouse cDNA microarray analysis uncovers Slug targets in mouse embryonic fibroblasts. Genomics 2006;87:113-8. [DOI: 10.1016/j.ygeno.2005.09.014] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.6] [Reference Citation Analysis]
2 Womer RB, Pressey JG. Rhabdomyosarcoma and soft tissue sarcoma in childhood: . Current Opinion in Oncology 2000;12:337-44. [DOI: 10.1097/00001622-200007000-00010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
3 Catalano A, Rodilossi S, Rippo MR, Caprari P, Procopio A. Induction of stem cell factor/c-Kit/slug signal transductionin multidrug-resistant malignant mesothelioma cells. J Biol Chem. 2004;279:46706-46714. [PMID: 15337769 DOI: 10.1074/jbc.M406696200] [Cited by in Crossref: 65] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
4 Yu Y, Khan J, Khanna C, Helman L, Meltzer PS, Merlino G. Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat Med. 2004;10:175-181. [PMID: 14704789 DOI: 10.1038/nm966] [Cited by in Crossref: 369] [Cited by in F6Publishing: 309] [Article Influence: 20.5] [Reference Citation Analysis]
5 Cobb LJ, Salih DA, Gonzalez I, Tripathi G, Carter EJ, Lovett F, Holding C, Pell JM. Partitioning of IGFBP-5 actions in myogenesis: IGF-independent anti-apoptotic function. J Cell Sci 2004;117:1737-46. [PMID: 15075235 DOI: 10.1242/jcs.01028] [Cited by in Crossref: 50] [Cited by in F6Publishing: 54] [Article Influence: 2.8] [Reference Citation Analysis]
6 Li CM, Guo M, Borczuk A, Powell CA, Wei M, Thaker HM, Friedman R, Klein U, Tycko B. Gene expression in Wilms' tumor mimics the earliest committed stage in the metanephric mesenchymal-epithelial transition. Am J Pathol 2002;160:2181-90. [PMID: 12057921 DOI: 10.1016/S0002-9440(10)61166-2] [Cited by in Crossref: 179] [Cited by in F6Publishing: 90] [Article Influence: 9.0] [Reference Citation Analysis]
7 Pérez-Mancera PA, González-Herrero I, Pérez-Caro M, Gutiérrez-Cianca N, Flores T, Gutiérrez-Adán A, Pintado B, Sánchez-Martín M, Sánchez-García I. SLUG in cancer development. Oncogene. 2005;24:3073-3082. [PMID: 15735690 DOI: 10.1038/sj.onc.1208505] [Cited by in Crossref: 77] [Cited by in F6Publishing: 75] [Article Influence: 4.5] [Reference Citation Analysis]
8 Anderson JL, Denny CT, Tap WD, Federman N. Pediatric sarcomas: translating molecular pathogenesis of disease to novel therapeutic possibilities. Pediatr Res 2012;72:112-21. [PMID: 22546864 DOI: 10.1038/pr.2012.54] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
9 Pruller J, Hofer I, Ganassi M, Heher P, Ma MT, Zammit PS. A human Myogenin promoter modified to be highly active in alveolar rhabdomyosarcoma drives an effective suicide gene therapy. Cancer Gene Ther 2021;28:427-41. [PMID: 32973362 DOI: 10.1038/s41417-020-00225-0] [Reference Citation Analysis]
10 Bisognin A, Bortoluzzi S, Danieli GA. Detection of chromosomal regions showing differential gene expression in human skeletal muscle and in alveolar rhabdomyosarcoma. BMC Bioinformatics 2004;5:68. [PMID: 15176974 DOI: 10.1186/1471-2105-5-68] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
11 Lacey A, Rodrigues-Hoffman A, Safe S. PAX3-FOXO1A Expression in Rhabdomyosarcoma Is Driven by the Targetable Nuclear Receptor NR4A1. Cancer Res 2017;77:732-41. [PMID: 27864345 DOI: 10.1158/0008-5472.CAN-16-1546] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
12 Grifone R, Demignon J, Giordani J, Niro C, Souil E, Bertin F, Laclef C, Xu P, Maire P. Eya1 and Eya2 proteins are required for hypaxial somitic myogenesis in the mouse embryo. Developmental Biology 2007;302:602-16. [DOI: 10.1016/j.ydbio.2006.08.059] [Cited by in Crossref: 108] [Cited by in F6Publishing: 99] [Article Influence: 7.2] [Reference Citation Analysis]
13 Hofmann W, de Vos S, Komor M, Hoelzer D, Wachsman W, Koeffler HP. Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow. Blood 2002;100:3553-60. [DOI: 10.1182/blood.v100.10.3553] [Cited by in Crossref: 170] [Cited by in F6Publishing: 49] [Article Influence: 8.5] [Reference Citation Analysis]
14 Gryder B, Nelson C, Shepard S. Biosemiotic Entropy of the Genome: Mutations and Epigenetic Imbalances Resulting in Cancer. Entropy 2013;15:234-61. [DOI: 10.3390/e15010234] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
15 Olanich ME, Barr FG. A call to ARMS: targeting the PAX3-FOXO1 gene in alveolar rhabdomyosarcoma. Expert Opin Ther Targets 2013;17:607-23. [PMID: 23432728 DOI: 10.1517/14728222.2013.772136] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
16 Naini S, Etheridge KT, Adam SJ, Qualman SJ, Bentley RC, Counter CM, Linardic CM. Defining the cooperative genetic changes that temporally drive alveolar rhabdomyosarcoma. Cancer Res 2008;68:9583-8. [PMID: 19047133 DOI: 10.1158/0008-5472.CAN-07-6178] [Cited by in Crossref: 55] [Cited by in F6Publishing: 41] [Article Influence: 4.2] [Reference Citation Analysis]
17 Tripathi G, Salih DA, Drozd AC, Cosgrove RA, Cobb LJ, Pell JM. IGF-independent effects of insulin-like growth factor binding protein-5 (Igfbp5) in vivo. FASEB J 2009;23:2616-26. [PMID: 19332648 DOI: 10.1096/fj.08-114124] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 3.9] [Reference Citation Analysis]
18 Davicioni E, Wai DH, Anderson MJ. Diagnostic and Prognostic Sarcoma Signatures. Mol Diag Ther 2008;12:359-74. [DOI: 10.1007/bf03256302] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
19 Gryder BE, Yohe ME, Chou HC, Zhang X, Marques J, Wachtel M, Schaefer B, Sen N, Song Y, Gualtieri A, Pomella S, Rota R, Cleveland A, Wen X, Sindiri S, Wei JS, Barr FG, Das S, Andresson T, Guha R, Lal-Nag M, Ferrer M, Shern JF, Zhao K, Thomas CJ, Khan J. PAX3-FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability. Cancer Discov 2017;7:884-99. [PMID: 28446439 DOI: 10.1158/2159-8290.CD-16-1297] [Cited by in Crossref: 116] [Cited by in F6Publishing: 76] [Article Influence: 23.2] [Reference Citation Analysis]
20 Tapscott SJ. The circuitry of a master switch: Myod and the regulation of skeletal muscle gene transcription. Development 2005;132:2685-95. [PMID: 15930108 DOI: 10.1242/dev.01874] [Cited by in Crossref: 493] [Cited by in F6Publishing: 476] [Article Influence: 29.0] [Reference Citation Analysis]
21 Xia SJ, Barr FG. Chromosome translocations in sarcomas and the emergence of oncogenic transcription factors. European Journal of Cancer 2005;41:2513-27. [DOI: 10.1016/j.ejca.2005.08.003] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
22 Saab R, Spunt SL, Skapek SX. Myogenesis and rhabdomyosarcoma the Jekyll and Hyde of skeletal muscle. Curr Top Dev Biol 2011;94:197-234. [PMID: 21295688 DOI: 10.1016/B978-0-12-380916-2.00007-3] [Cited by in Crossref: 55] [Cited by in F6Publishing: 38] [Article Influence: 5.0] [Reference Citation Analysis]
23 Zeng J, Shi R, Cai CX, Liu XR, Song YB, Wei M, Ma WL. Increased expression of Six1 correlates with progression and prognosis of prostate cancer. Cancer Cell Int 2015;15:63. [PMID: 26161040 DOI: 10.1186/s12935-015-0215-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
24 Olmos D, Tan DS, Jones RL, Judson IR. Biological rationale and current clinical experience with anti-insulin-like growth factor 1 receptor monoclonal antibodies in treating sarcoma: twenty years from the bench to the bedside. Cancer J 2010;16:183-94. [PMID: 20526094 DOI: 10.1097/PPO.0b013e3181dbebf9] [Cited by in Crossref: 53] [Cited by in F6Publishing: 37] [Article Influence: 4.4] [Reference Citation Analysis]
25 Böhm M, Wachtel M, Marques JG, Streiff N, Laubscher D, Nanni P, Mamchaoui K, Santoro R, Schäfer BW. Helicase CHD4 is an epigenetic coregulator of PAX3-FOXO1 in alveolar rhabdomyosarcoma. J Clin Invest 2016;126:4237-49. [PMID: 27760049 DOI: 10.1172/JCI85057] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
26 Nabarro S, Himoudi N, Papanastasiou A, Gilmour K, Gibson S, Sebire N, Thrasher A, Blundell MP, Hubank M, Canderan G, Anderson J. Coordinated oncogenic transformation and inhibition of host immune responses by the PAX3-FKHR fusion oncoprotein. J Exp Med 2005;202:1399-410. [PMID: 16287709 DOI: 10.1084/jem.20050730] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 2.5] [Reference Citation Analysis]
27 Pérez-losada J, Sánchez-martı́n M, Rodrı́guez-garcı́a A, Sánchez ML, Orfao A, Flores T, Sánchez-garcı́a I. Zinc-finger transcription factor Slug contributes to the function of the stem cell factor c-kit signaling pathway. Blood 2002;100:1274-86. [DOI: 10.1182/blood.v100.4.1274.h81602001274_1274_1286] [Cited by in Crossref: 120] [Article Influence: 6.0] [Reference Citation Analysis]
28 Randall RL, Wade M, Albritton KH, Coffin CM, Joyner DE. Validation of cDNA Microarray Analysis to Distinguish Tumor Type Ex Vivo: . Clinical Orthopaedics and Related Research 2003;415:S110-9. [DOI: 10.1097/01.blo0000093060.96273.db] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
29 Ying-Hao S, Qing Y, Lin-Hui W, Li G, Rong T, Kang Y, Chuan-Liang X, Song-Xi Q, Yao L, Yi X, Yu-Ming M. Monitoring gene expression profile changes in bladder transitional cell carcinoma using cDNA microarray. Urol Oncol 2002;7:207-12. [PMID: 12644218 DOI: 10.1016/s1078-1439(02)00192-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
30 Farini A, Razini P, Erratico S, Torrente Y, Meregalli M. Cell based therapy for Duchenne muscular dystrophy. J Cell Physiol 2009;221:526-34. [PMID: 19688776 DOI: 10.1002/jcp.21895] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 3.0] [Reference Citation Analysis]
31 Gong HM, Wang J, Xu J, Zhou ZY, Li JW, Chen SF. Identification of rare paired box 3 variant in strabismus by whole exome sequencing. Int J Ophthalmol 2017;10:1223-8. [PMID: 28861346 DOI: 10.18240/ijo.2017.08.06] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
32 Subramani P, Sahu R, Verma S. Feature selection using Haar wavelet power spectrum. BMC Bioinformatics 2006;7:432. [PMID: 17022808 DOI: 10.1186/1471-2105-7-432] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
33 Wu W, Ren Z, Zhang L, Liu Y, Li H, Xiong Y. Overexpression of Six1 gene suppresses proliferation and enhances expression of fast-type muscle genes in C2C12 myoblasts. Mol Cell Biochem 2013;380:23-32. [PMID: 23613228 DOI: 10.1007/s11010-013-1653-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
34 Parham DM, Barr FG. Classification of rhabdomyosarcoma and its molecular basis. Adv Anat Pathol. 2013;20:387-397. [PMID: 24113309 DOI: 10.1097/pap.0b013e3182a92d0d] [Cited by in Crossref: 146] [Cited by in F6Publishing: 73] [Article Influence: 18.3] [Reference Citation Analysis]
35 Clarkson RW, Watson CJ. Microarray analysis of the involution switch. J Mammary Gland Biol Neoplasia 2003;8:309-19. [PMID: 14973375 DOI: 10.1023/b:jomg.0000010031.53310.92] [Cited by in Crossref: 49] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
36 Gonzalez Curto G, Der Vartanian A, Frarma YE, Manceau L, Baldi L, Prisco S, Elarouci N, Causeret F, Korenkov D, Rigolet M, Aurade F, De Reynies A, Contremoulins V, Relaix F, Faklaris O, Briscoe J, Gilardi-Hebenstreit P, Ribes V. The PAX-FOXO1s trigger fast trans-differentiation of chick embryonic neural cells into alveolar rhabdomyosarcoma with tissue invasive properties limited by S phase entry inhibition. PLoS Genet 2020;16:e1009164. [PMID: 33175861 DOI: 10.1371/journal.pgen.1009164] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Astolfi A, De Giovanni C, Landuzzi L, Nicoletti G, Ricci C, Croci S, Scopece L, Nanni P, Lollini PL. Identification of new genes related to the myogenic differentiation arrest of human rhabdomyosarcoma cells. Gene. 2001;274:139-149. [PMID: 11675006 DOI: 10.1016/s0378-1119(01)00619-9] [Cited by in Crossref: 38] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
38 Wachtel M, Schäfer BW. Unpeaceful roles of mutant PAX proteins in cancer. Seminars in Cell & Developmental Biology 2015;44:126-34. [DOI: 10.1016/j.semcdb.2015.09.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
39 Baer C, Nees M, Breit S, Selle B, Kulozik AE, Schaefer KL, Braun Y, Wai D, Poremba C. Profiling and functional annotation of mRNA gene expression in pediatric rhabdomyosarcoma and Ewing's sarcoma. Int J Cancer 2004;110:687-94. [PMID: 15146558 DOI: 10.1002/ijc.20171] [Cited by in Crossref: 62] [Cited by in F6Publishing: 50] [Article Influence: 3.4] [Reference Citation Analysis]
40 Pérez-Mancera PA, Bermejo-Rodríguez C, González-Herrero I, Herranz M, Flores T, Jiménez R, Sánchez-García I. Adipose tissue mass is modulated by SLUG (SNAI2). Hum Mol Genet 2007;16:2972-86. [PMID: 17905753 DOI: 10.1093/hmg/ddm278] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 2.5] [Reference Citation Analysis]
41 Yen PM, Feng X, Flamant F, Chen Y, Walker RL, Weiss RE, Chassande O, Samarut J, Refetoff S, Meltzer PS. Effects of ligand and thyroid hormone receptor isoforms on hepatic gene expression profiles of thyroid hormone receptor knockout mice. EMBO Rep 2003;4:581-7. [PMID: 12776178 DOI: 10.1038/sj.embor.embor862] [Cited by in Crossref: 89] [Cited by in F6Publishing: 85] [Article Influence: 4.9] [Reference Citation Analysis]
42 Tognon C, Knezevich SR, Huntsman D, Roskelley CD, Melnyk N, Mathers JA, Becker L, Carneiro F, MacPherson N, Horsman D, Poremba C, Sorensen PH. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell 2002;2:367-76. [PMID: 12450792 DOI: 10.1016/s1535-6108(02)00180-0] [Cited by in Crossref: 575] [Cited by in F6Publishing: 239] [Article Influence: 30.3] [Reference Citation Analysis]
43 Elfman J, Pham LP, Li H. The relationship between chimeric RNAs and gene fusions: Potential implications of reciprocity in cancer. J Genet Genomics 2020;47:341-8. [PMID: 33008771 DOI: 10.1016/j.jgg.2020.04.005] [Reference Citation Analysis]
44 Bahn S, Augood SJ, Ryan M, Standaert DG, Starkey M, Emson PC. Gene expression profiling in the post-mortem human brain--no cause for dismay. J Chem Neuroanat 2001;22:79-94. [PMID: 11470556 DOI: 10.1016/s0891-0618(01)00099-0] [Cited by in Crossref: 111] [Cited by in F6Publishing: 36] [Article Influence: 5.3] [Reference Citation Analysis]
45 Nishijo K, Chen QR, Zhang L, McCleish AT, Rodriguez A, Cho MJ, Prajapati SI, Gelfond JA, Chisholm GB, Michalek JE, Aronow BJ, Barr FG, Randall RL, Ladanyi M, Qualman SJ, Rubin BP, LeGallo RD, Wang C, Khan J, Keller C. Credentialing a preclinical mouse model of alveolar rhabdomyosarcoma. Cancer Res 2009;69:2902-11. [PMID: 19339268 DOI: 10.1158/0008-5472.CAN-08-3723] [Cited by in Crossref: 57] [Cited by in F6Publishing: 49] [Article Influence: 4.4] [Reference Citation Analysis]
46 Hamalainen H, Tubman J, Vikman S, Kyrölä T, Ylikoski E, Warrington J, Lahesmaa R. Identification and Validation of Endogenous Reference Genes for Expression Profiling of T Helper Cell Differentiation by Quantitative Real-Time RT-PCR. Analytical Biochemistry 2001;299:63-70. [DOI: 10.1006/abio.2001.5369] [Cited by in Crossref: 187] [Cited by in F6Publishing: 171] [Article Influence: 8.9] [Reference Citation Analysis]
47 Popov VM, Wu K, Zhou J, Powell MJ, Mardon G, Wang C, Pestell RG. The Dachshund gene in development and hormone-responsive tumorigenesis. Trends Endocrinol Metab 2010;21:41-9. [PMID: 19896866 DOI: 10.1016/j.tem.2009.08.002] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 3.9] [Reference Citation Analysis]
48 Fredericks WJ, Ayyanathan K, Herlyn M, Friedman JR, Rauscher FJ 3rd. An engineered PAX3-KRAB transcriptional repressor inhibits the malignant phenotype of alveolar rhabdomyosarcoma cells harboring the endogenous PAX3-FKHR oncogene. Mol Cell Biol 2000;20:5019-31. [PMID: 10866659 DOI: 10.1128/MCB.20.14.5019-5031.2000] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
49 Ahn EH, Mercado GE, Laé M, Ladanyi M. Identification of target genes of PAX3-FOXO1 in alveolar rhabdomyosarcoma. Oncol Rep 2013;30:968-78. [PMID: 23733015 DOI: 10.3892/or.2013.2513] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
50 Kelleher FC, Cain JE, Healy JM, Watkins DN, Thomas DM. Prevailing importance of the hedgehog signaling pathway and the potential for treatment advancement in sarcoma. Pharmacol Ther 2012;136:153-68. [PMID: 22906929 DOI: 10.1016/j.pharmthera.2012.08.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
51 Liu YB, Wei ZX, Li L, Li HS, Chen H, Li XW. Construction and analysis of SSH cDNA library of human vascular endothelial cells related to gastrocarcinoma. World J Gastroenterol 2003; 9(11): 2419-2423 [PMID: 14606068 DOI: 10.3748/wjg.v9.i11.2419] [Cited by in CrossRef: 1] [Article Influence: 0.1] [Reference Citation Analysis]
52 Ha YM, Nam JO, Kang YJ. Pitavastatin Regulates Ang II Induced Proliferation and Migration via IGFBP-5 in VSMC. Korean J Physiol Pharmacol 2015;19:499-506. [PMID: 26557016 DOI: 10.4196/kjpp.2015.19.6.499] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
53 Zhang X, Xu R. Six1 expression is associated with a poor prognosis in patients with glioma. Oncol Lett 2017;13:1293-8. [PMID: 28454249 DOI: 10.3892/ol.2017.5577] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
54 Christensen KL, Patrick AN, McCoy EL, Ford HL. The six family of homeobox genes in development and cancer. Adv Cancer Res 2008;101:93-126. [PMID: 19055944 DOI: 10.1016/S0065-230X(08)00405-3] [Cited by in Crossref: 89] [Cited by in F6Publishing: 70] [Article Influence: 6.8] [Reference Citation Analysis]
55 Rossi S, Poliani PL, Missale C, Monti E, Fanzani A. Caveolins in rhabdomyosarcoma. J Cell Mol Med 2011;15:2553-68. [PMID: 21707915 DOI: 10.1111/j.1582-4934.2011.01364.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
56 Ciemerych MA, Archacka K, Grabowska I, Przewoźniak M. Cell Cycle Regulation During Proliferation and Differentiation of Mammalian Muscle Precursor Cells. In: Kubiak JZ, editor. Cell Cycle in Development. Berlin: Springer Berlin Heidelberg; 2011. pp. 473-527. [DOI: 10.1007/978-3-642-19065-0_20] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
57 Winter SS, Jiang Z, Khawaja HM, Griffin T, Devidas M, Asselin BL, Larson RS; Children's Oncology Group. Identification of genomic classifiers that distinguish induction failure in T-lineage acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood 2007;110:1429-38. [PMID: 17495134 DOI: 10.1182/blood-2006-12-059790] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 2.6] [Reference Citation Analysis]
58 De Giovanni C, Landuzzi L, Nicoletti G, Lollini P, Nanni P. Molecular and cellular biology of rhabdomyosarcoma. Future Oncology 2009;5:1449-75. [DOI: 10.2217/fon.09.97] [Cited by in Crossref: 71] [Cited by in F6Publishing: 64] [Article Influence: 5.5] [Reference Citation Analysis]
59 Shao WH, Eisenberg RA, Cohen PL. The Mer receptor tyrosine kinase is required for the loss of B cell tolerance in the chronic graft-versus-host disease model of systemic lupus erythematosus. J Immunol 2008;180:7728-35. [PMID: 18490777 DOI: 10.4049/jimmunol.180.11.7728] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
60 Begum S, Emami N, Cheung A, Wilkins O, Der S, Hamel PA. Cell-type-specific regulation of distinct sets of gene targets by Pax3 and Pax3/FKHR. Oncogene 2005;24:1860-72. [PMID: 15688035 DOI: 10.1038/sj.onc.1208315] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 2.4] [Reference Citation Analysis]
61 Fougerousse F, Durand M, Lopez S, Suel L, Demignon J, Thornton C, Ozaki H, Kawakami K, Barbet P, Beckmann JS, Maire P. Six and Eya expression during human somitogenesis and MyoD gene family activation. J Muscle Res Cell Motil 2002;23:255-64. [PMID: 12500905 DOI: 10.1023/a:1020990825644] [Cited by in Crossref: 45] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
62 Hu P, Geles KG, Paik JH, DePinho RA, Tjian R. Codependent activators direct myoblast-specific MyoD transcription. Dev Cell 2008;15:534-46. [PMID: 18854138 DOI: 10.1016/j.devcel.2008.08.018] [Cited by in Crossref: 93] [Cited by in F6Publishing: 89] [Article Influence: 6.6] [Reference Citation Analysis]
63 Anderson J, Ramsay A, Gould S, Pritchard-Jones K. PAX3-FKHR induces morphological change and enhances cellular proliferation and invasion in rhabdomyosarcoma. Am J Pathol 2001;159:1089-96. [PMID: 11549601 DOI: 10.1016/S0002-9440(10)61784-1] [Cited by in Crossref: 54] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
64 Jividen K, Li H. Chimeric RNAs generated by intergenic splicing in normal and cancer cells. Genes Chromosomes Cancer 2014;53:963-71. [PMID: 25131334 DOI: 10.1002/gcc.22207] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 6.5] [Reference Citation Analysis]
65 Ding J, Xia Y, Yu Z, Wen J, Zhang Z, Zhang Z, Liu Z, Jiang Z, Liu H, Liao G. Identification of upstream miRNAs of SNAI2 and their influence on the metastasis of gastrointestinal stromal tumors. Cancer Cell Int 2019;19:289. [PMID: 31749661 DOI: 10.1186/s12935-019-1006-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
66 Relaix F, Polimeni M, Rocancourt D, Ponzetto C, Schäfer BW, Buckingham M. The transcriptional activator PAX3-FKHR rescues the defects of Pax3 mutant mice but induces a myogenic gain-of-function phenotype with ligand-independent activation of Met signaling in vivo. Genes Dev 2003;17:2950-65. [PMID: 14665670 DOI: 10.1101/gad.281203] [Cited by in Crossref: 113] [Cited by in F6Publishing: 112] [Article Influence: 6.3] [Reference Citation Analysis]
67 Graf Finckenstein F, Shahbazian V, Davicioni E, Ren Y, Anderson MJ. PAX-FKHR function as pangenes by simultaneously inducing and inhibiting myogenesis. Oncogene 2008;27:2004-14. [DOI: 10.1038/sj.onc.1210835] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
68 Tagawa ST, Akhtar NH, Robinson BD, Beltran H. Uncommon Cancers of the Prostate. In: Raghavan D, Blanke CD, Johnson DH, Moots PL, Reaman GH, Rose PG, Sekeres MA, editors. Textbook of Uncommon Cancer. Hoboken: John Wiley & Sons, Inc.; 2012. pp. 47-75. [DOI: 10.1002/9781118464557.ch4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
69 Ford HL, Landesman-bollag E, Dacwag CS, Stukenberg P, Pardee AB, Seldin DC. Cell Cycle-regulated Phosphorylation of the Human SIX1 Homeodomain Protein. Journal of Biological Chemistry 2000;275:22245-54. [DOI: 10.1074/jbc.m002446200] [Cited by in Crossref: 84] [Cited by in F6Publishing: 47] [Article Influence: 3.8] [Reference Citation Analysis]
70 Wu W, Ren Z, Liu H, Wang L, Huang R, Chen J, Zhang L, Li P, Xiong Y. Core promoter analysis of porcine Six1 gene and its regulation of the promoter activity by CpG methylation. Gene 2013;529:238-44. [DOI: 10.1016/j.gene.2013.07.102] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
71 Folpe AL. MyoD1 and myogenin expression in human neoplasia: a review and update. Adv Anat Pathol 2002;9:198-203. [PMID: 11981115 DOI: 10.1097/00125480-200205000-00003] [Cited by in Crossref: 56] [Cited by in F6Publishing: 40] [Article Influence: 2.8] [Reference Citation Analysis]
72 Asakura A, Rudnicki MA. Rhabdomyosarcomagenesis-Novel pathway found. Cancer Cell 2003;4:421-2. [PMID: 14706332 DOI: 10.1016/s1535-6108(03)00313-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
73 Kim HN, Choi DW, Lee KT, Lee JK, Heo JS, Choi SH, Paik SW, Rhee JC, Lowe AW. Gene expression profiling in lymph node-positive and lymph node-negative pancreatic cancer. Pancreas 2007;34:325-34. [PMID: 17414055 DOI: 10.1097/MPA.0b013e3180317b01] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
74 Feng X, Jiang Y, Meltzer P, Yen PM. Transgenic targeting of a dominant negative corepressor to liver blocks basal repression by thyroid hormone receptor and increases cell proliferation. J Biol Chem 2001;276:15066-72. [PMID: 11328825 DOI: 10.1074/jbc.m011027200] [Cited by in Crossref: 35] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
75 Chao L, Liu J, Zhao D. Increased Six1 expression is associated with poor prognosis in patients with osteosarcoma. Oncol Lett 2017;13:2891-6. [PMID: 28521394 DOI: 10.3892/ol.2017.5803] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
76 Dodd RD, Mito JK, Kirsch DG. Animal models of soft-tissue sarcoma. Dis Model Mech 2010;3:557-66. [PMID: 20713645 DOI: 10.1242/dmm.005223] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
77 Carter KL, Cahir-McFarland E, Kieff E. Epstein-barr virus-induced changes in B-lymphocyte gene expression. J Virol. 2002;76:10427-10436. [PMID: 12239319 DOI: 10.1128/jvi.76.20.10427-10436.2002] [Cited by in Crossref: 108] [Cited by in F6Publishing: 74] [Article Influence: 5.4] [Reference Citation Analysis]
78 Suvà M, Cironi L, Riggi N, Stamenkovic I. Sarcomas: genetics, signalling, and cellular origins. Part 2: TET-independent fusion proteins and receptor tyrosine kinase mutations. J Pathol 2007;213:117-30. [DOI: 10.1002/path.2208] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
79 Barber TD, Barber MC, Tomescu O, Barr FG, Ruben S, Friedman TB. Identification of target genes regulated by PAX3 and PAX3-FKHR in embryogenesis and alveolar rhabdomyosarcoma. Genomics 2002;79:278-84. [PMID: 11863357 DOI: 10.1006/geno.2002.6703] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 2.4] [Reference Citation Analysis]
80 He XH, Li JJ, Xie YH, Tang YT, Yao GF, Qin WX, Wan DF, Gu JR. Altered gene expression profiles of NIH3T3 cells regulated by human lung cancer associated gene CT120. Cell Res 2004;14:487-96. [PMID: 15625016 DOI: 10.1038/sj.cr.7290252] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
81 Seki M, Narusaka M, Yamaguchi-shinozaki K, Carninci P, Kawai J, Hayashizaki Y, Shinozaki K. Arabidopsis encyclopedia using full-length cDNAs and its application. Plant Physiology and Biochemistry 2001;39:211-20. [DOI: 10.1016/s0981-9428(01)01244-x] [Cited by in Crossref: 23] [Article Influence: 1.1] [Reference Citation Analysis]
82 Marshall AD, Grosveld GC. Alveolar rhabdomyosarcoma - The molecular drivers of PAX3/7-FOXO1-induced tumorigenesis. Skelet Muscle 2012;2:25. [PMID: 23206814 DOI: 10.1186/2044-5040-2-25] [Cited by in Crossref: 57] [Cited by in F6Publishing: 46] [Article Influence: 5.7] [Reference Citation Analysis]
83 Yamasaki R, Yokota K, Okada H, Hayashi S, Mizuno M, Yoshino T, Hirai Y, Saitou D, Akagi T, Oguma K. Immune response in Helicobacter pylori-induced low-grade gastric-mucosa-associated lymphoid tissue (MALT) lymphoma. J Med Microbiol. 2004;53:21-29. [PMID: 14663101 DOI: 10.1099/jmm.0.05348-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
84 Hakozaki M, Hojo H, Tajino T, Yamada H, Kikuchi S, Kikuta A, Konno S, Abe M. Therapeutic cytodifferentiation in alveolar rhabdomyosarcoma without genetic change of the PAX3-FKHR chimeric fusion gene: a case study. Hum Cell 2013;26:149-54. [PMID: 23797277 DOI: 10.1007/s13577-013-0067-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
85 Akalin I, Kutlay NY, Ilhan O, Tukun A. Novel chromosomal translocations in multiple myeloma: t(13;16)(q14;q24) and t(1;15)(q10;q26). Int J Lab Hematol 2007;29:215-20. [PMID: 17474900 DOI: 10.1111/j.1751-553X.2006.00837.x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
86 Kurmasheva RT, Peterson CA, Parham DM, Chen B, McDonald RE, Cooney CA. Upstream CpG island methylation of the PAX3 gene in human rhabdomyosarcomas. Pediatr Blood Cancer 2005;44:328-37. [PMID: 15602708 DOI: 10.1002/pbc.20285] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
87 Keating AK, Salzberg DB, Sather S, Liang X, Nickoloff S, Anwar A, Deryckere D, Hill K, Joung D, Sawczyn KK, Park J, Curran-Everett D, McGavran L, Meltesen L, Gore L, Johnson GL, Graham DK. Lymphoblastic leukemia/lymphoma in mice overexpressing the Mer (MerTK) receptor tyrosine kinase. Oncogene 2006;25:6092-100. [PMID: 16652142 DOI: 10.1038/sj.onc.1209633] [Cited by in Crossref: 69] [Cited by in F6Publishing: 68] [Article Influence: 4.3] [Reference Citation Analysis]
88 Coletta RD, Christensen K, Reichenberger KJ, Lamb J, Micomonaco D, Huang L, Wolf DM, Müller-Tidow C, Golub TR, Kawakami K, Ford HL. The Six1 homeoprotein stimulates tumorigenesis by reactivation of cyclin A1. Proc Natl Acad Sci U S A 2004;101:6478-83. [PMID: 15123840 DOI: 10.1073/pnas.0401139101] [Cited by in Crossref: 150] [Cited by in F6Publishing: 143] [Article Influence: 8.3] [Reference Citation Analysis]
89 Linardic CM. PAX3-FOXO1 fusion gene in rhabdomyosarcoma. Cancer Lett 2008;270:10-8. [PMID: 18457914 DOI: 10.1016/j.canlet.2008.03.035] [Cited by in Crossref: 90] [Cited by in F6Publishing: 77] [Article Influence: 6.4] [Reference Citation Analysis]
90 Mayanil C, George D, Freilich L, Miljan EJ, Mania-farnell B, Mclone DG, Bremer EG. Microarray Analysis Detects Novel Pax3 Downstream Target Genes. Journal of Biological Chemistry 2001;276:49299-309. [DOI: 10.1074/jbc.m107933200] [Cited by in Crossref: 83] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
91 Watson SJ, Meng F, Thompson RC, Akil H. The “chip” as a specific genetic tool. Biological Psychiatry 2000;48:1147-56. [DOI: 10.1016/s0006-3223(00)01080-5] [Cited by in Crossref: 31] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
92 Azorsa DO, Bode PK, Wachtel M, Cheuk ATC, Meltzer PS, Vokuhl C, Camenisch U, Khov HL, Bode B, Schäfer BW, Khan J. Immunohistochemical detection of PAX-FOXO1 fusion proteins in alveolar rhabdomyosarcoma using breakpoint specific monoclonal antibodies. Mod Pathol 2021;34:748-57. [PMID: 33299109 DOI: 10.1038/s41379-020-00719-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
93 Coletta RD, McCoy EL, Burns V, Kawakami K, McManaman JL, Wysolmerski JJ, Ford HL. Characterization of the Six1 homeobox gene in normal mammary gland morphogenesis. BMC Dev Biol 2010;10:4. [PMID: 20074369 DOI: 10.1186/1471-213X-10-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
94 Martín Liberal J, Lagares-Tena L, Sáinz-Jaspeado M, Mateo-Lozano S, García Del Muro X, Tirado OM. Targeted therapies in sarcomas: challenging the challenge. Sarcoma 2012;2012:626094. [PMID: 22701332 DOI: 10.1155/2012/626094] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
95 Napoli C, de Nigris F, Welch JS, Calara FB, Stuart RO, Glass CK, Palinski W. Maternal Hypercholesterolemia During Pregnancy Promotes Early Atherogenesis in LDL Receptor-Deficient Mice and Alters Aortic Gene Expression Determined by Microarray. Circulation 2002;105:1360-7. [DOI: 10.1161/hc1102.106792] [Cited by in Crossref: 103] [Cited by in F6Publishing: 108] [Article Influence: 5.2] [Reference Citation Analysis]
96 Palinski W, Napoli C. The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol‐lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis. FASEB j 2002;16:1348-60. [DOI: 10.1096/fj.02-0226rev] [Cited by in Crossref: 175] [Cited by in F6Publishing: 161] [Article Influence: 8.8] [Reference Citation Analysis]
97 Zanola A, Rossi S, Faggi F, Monti E, Fanzani A. Rhabdomyosarcomas: an overview on the experimental animal models. J Cell Mol Med 2012;16:1377-91. [PMID: 22225829 DOI: 10.1111/j.1582-4934.2011.01518.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
98 Cai D, McCarron RM, Hallenbeck J. Cloning and characterization of a forkhead transcription factor gene, FoxO1a, from thirteen-lined ground squirrel. Gene 2004;343:203-9. [PMID: 15563846 DOI: 10.1016/j.gene.2004.09.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
99 Pal A, Chiu HY, Taneja R. Genetics, epigenetics and redox homeostasis in rhabdomyosarcoma: Emerging targets and therapeutics. Redox Biol 2019;25:101124. [PMID: 30709791 DOI: 10.1016/j.redox.2019.101124] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
100 Pérez-losada J, Sánchez-martín M, Pérez-caro M, Pérez-mancera PA, Sánchez-garcía I. The radioresistance biological function of the SCF/kit signaling pathway is mediated by the zinc-finger transcription factor Slug. Oncogene 2003;22:4205-11. [DOI: 10.1038/sj.onc.1206467] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 3.3] [Reference Citation Analysis]
101 Rudnik-Schöneborn S, Anhuf D, Koscielniak E, Zerres K. Alveolar rhabdomyosarcoma in infantile spinal muscular atrophy: coincidence or predisposition? Neuromuscul Disord 2005;15:45-7. [PMID: 15639120 DOI: 10.1016/j.nmd.2004.09.013] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
102 Lesluyes T, Delespaul L, Coindre JM, Chibon F. The CINSARC signature as a prognostic marker for clinical outcome in multiple neoplasms. Sci Rep 2017;7:5480. [PMID: 28710396 DOI: 10.1038/s41598-017-05726-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
103 Ridgeway AG, Skerjanc IS. Pax3 Is Essential for Skeletal Myogenesis and the Expression of Six1 and Eya2. Journal of Biological Chemistry 2001;276:19033-9. [DOI: 10.1074/jbc.m011491200] [Cited by in Crossref: 104] [Cited by in F6Publishing: 46] [Article Influence: 5.0] [Reference Citation Analysis]
104 Bean C, Salamon M, Raffaello A, Campanaro S, Pallavicini A, Lanfranchi G. The Ankrd2, Cdkn1c and Calcyclin Genes are Under the Control of MyoD During Myogenic Differentiation. Journal of Molecular Biology 2005;349:349-66. [DOI: 10.1016/j.jmb.2005.03.063] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
105 Mano H. Stratification of Acute Myeloid Leukemia Based on Gene Expression Profiles. International Journal of Hematology 2004;80:389-94. [DOI: 10.1532/ijh97.04111] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
106 Raetz EA, Moos PJ, Szabo A, Carroll WL. GENE EXPRESSION PROFILING. Hematology/Oncology Clinics of North America 2001;15:911-30. [DOI: 10.1016/s0889-8588(05)70257-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
107 Keller C, Guttridge DC. Mechanisms of impaired differentiation in rhabdomyosarcoma. FEBS J. 2013;280:4323-4334. [PMID: 23822136 DOI: 10.1111/febs.12421] [Cited by in Crossref: 74] [Cited by in F6Publishing: 67] [Article Influence: 8.2] [Reference Citation Analysis]
108 Staudt LM. Gene expression physiology and pathophysiology of the immune system. Trends in Immunology 2001;22:35-40. [DOI: 10.1016/s1471-4906(00)01792-0] [Cited by in Crossref: 47] [Cited by in F6Publishing: 2] [Article Influence: 2.2] [Reference Citation Analysis]
109 Chauhan S, Kunz S, Davis K, Roberts J, Martin G, Demetriou MC, Sroka TC, Cress AE, Miesfeld RL. Androgen control of cell proliferation and cytoskeletal reorganization in human fibrosarcoma cells: role of RhoB signaling. J Biol Chem 2004;279:937-44. [PMID: 14576147 DOI: 10.1074/jbc.M311325200] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
110 Khan J, Wei JS, Ringnér M, Saal LH, Ladanyi M, Westermann F, Berthold F, Schwab M, Antonescu CR, Peterson C, Meltzer PS. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med 2001;7:673-9. [PMID: 11385503 DOI: 10.1038/89044] [Cited by in Crossref: 1659] [Cited by in F6Publishing: 983] [Article Influence: 79.0] [Reference Citation Analysis]
111 Mackall CL, Meltzer PS, Helman LJ. Focus on sarcomas. Cancer Cell 2002;2:175-8. [DOI: 10.1016/s1535-6108(02)00132-0] [Cited by in Crossref: 67] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
112 Picarsic J, Reyes-múgica M. Phenotype and Immunophenotype of the Most Common Pediatric Tumors. Applied Immunohistochemistry & Molecular Morphology 2015;23:313-26. [DOI: 10.1097/pai.0000000000000068] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
113 Lagha M, Sato T, Regnault B, Cumano A, Zuniga A, Licht J, Relaix F, Buckingham M. Transcriptome analyses based on genetic screens for Pax3 myogenic targets in the mouse embryo. BMC Genomics 2010;11:696. [PMID: 21143873 DOI: 10.1186/1471-2164-11-696] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
114 Celis JE, Kruhøffer M, Gromova I, Frederiksen C, Østergaard M, Thykjaer T, Gromov P, Yu J, Pálsdóttir H, Magnusson N, Ørntoft TF. Gene expression profiling: monitoring transcription and translation products using DNA microarrays and proteomics. FEBS Letters 2000;480:2-16. [DOI: 10.1016/s0014-5793(00)01771-3] [Cited by in Crossref: 212] [Cited by in F6Publishing: 31] [Article Influence: 9.6] [Reference Citation Analysis]
115 Haupt S, Alsheich-bartok O, Haupt Y. Clues from worms: a Slug at Puma promotes the survival of blood progenitors. Cell Death Differ 2006;13:913-5. [DOI: 10.1038/sj.cdd.4401906] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
116 Tran H, Brunet A, Griffith EC, Greenberg ME. The Many Forks in FOXO's Road. Science Signaling 2003;2003:re5-re5. [DOI: 10.1126/stke.2003.172.re5] [Cited by in Crossref: 72] [Cited by in F6Publishing: 191] [Article Influence: 3.8] [Reference Citation Analysis]
117 Linger RM, Keating AK, Earp HS, Graham DK. Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors. Expert Opin Ther Targets 2010;14:1073-90. [PMID: 20809868 DOI: 10.1517/14728222.2010.515980] [Cited by in Crossref: 113] [Cited by in F6Publishing: 99] [Article Influence: 10.3] [Reference Citation Analysis]
118 Hong H, Tong W, Perkins R, Fang H, Xie Q, Shi L. Multiclass Decision Forest—A Novel Pattern Recognition Method for Multiclass Classification in Microarray Data Analysis. DNA and Cell Biology 2004;23:685-94. [DOI: 10.1089/dna.2004.23.685] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
119 Diesen DL, Skinner MA. Head and Neck Tumors. In: Carachi R, Grosfeld JL, Azmy AF, editors. The Surgery of Childhood Tumors. Berlin: Springer Berlin Heidelberg; 2008. pp. 353-86. [DOI: 10.1007/978-3-540-29734-5_17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
120 Laé M, Ahn EH, Mercado GE, Chuai S, Edgar M, Pawel BR, Olshen A, Barr FG, Ladanyi M. Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas. J Pathol 2007;212:143-51. [PMID: 17471488 DOI: 10.1002/path.2170] [Cited by in Crossref: 99] [Cited by in F6Publishing: 83] [Article Influence: 6.6] [Reference Citation Analysis]
121 Helman LJ, Meltzer P. Mechanisms of sarcoma development. Nat Rev Cancer 2003;3:685-94. [DOI: 10.1038/nrc1168] [Cited by in Crossref: 314] [Cited by in F6Publishing: 271] [Article Influence: 16.5] [Reference Citation Analysis]
122 Lu Y, Williamson D, Wang R, Summersgill B, Rodriguez S, Rogers S, Pritchard-jones K, Campbell C, Shipley J. Expression profiling targeting chromosomes for tumor classification and prediction of clinical behavior. Genes Chromosom Cancer 2003;38:207-14. [DOI: 10.1002/gcc.10276] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
123 de Benedetti V, Biglia N, Sismondi P, de Bortoli M. DNA Chips: The Future of Biomarkers. Int J Biol Markers 2000;15:1-9. [DOI: 10.1177/172460080001500101] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
124 Olguín HC, Pisconti A. Marking the tempo for myogenesis: Pax7 and the regulation of muscle stem cell fate decisions. J Cell Mol Med 2012;16:1013-25. [PMID: 21615681 DOI: 10.1111/j.1582-4934.2011.01348.x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 59] [Article Influence: 7.0] [Reference Citation Analysis]
125 Mong JA, Krebs C, Pfaff DW. Perspective: micoarrays and differential display PCR-tools for studying transcript levels of genes in neuroendocrine systems. Endocrinology 2002;143:2002-6. [PMID: 12021161 DOI: 10.1210/endo.143.6.8866] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
126 Miyazato A, Ueno S, Ohmine K, Ueda M, Yoshida K, Yamashita Y, Kaneko T, Mori M, Kirito K, Toshima M, Nakamura Y, Saito K, Kano Y, Furusawa S, Ozawa K, Mano H. Identification of myelodysplastic syndrome–specific genes by DNA microarray analysis with purified hematopoietic stem cell fraction. Blood 2001;98:422-7. [DOI: 10.1182/blood.v98.2.422] [Cited by in Crossref: 116] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
127 Salih DA, Tripathi G, Holding C, Szestak TA, Gonzalez MI, Carter EJ, Cobb LJ, Eisemann JE, Pell JM. Insulin-like growth factor-binding protein 5 (Igfbp5) compromises survival, growth, muscle development, and fertility in mice. Proc Natl Acad Sci U S A 2004;101:4314-9. [PMID: 15010534 DOI: 10.1073/pnas.0400230101] [Cited by in Crossref: 115] [Cited by in F6Publishing: 113] [Article Influence: 6.4] [Reference Citation Analysis]
128 Pérez-caro M, Sánchez-garcia I. BCR-ABL and Human Cancer. In: Srivastava R, editor. Apoptosis, Cell Signaling, and Human Diseases. Totowa: Humana Press; 2007. pp. 3-34. [DOI: 10.1007/978-1-59745-200-7_1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
129 Hu Q, Yuan Y, Wang C. Structural and functional studies of FKHR-PAX3, a reciprocal fusion gene of the t(2;13) chromosomal translocation in alveolar rhabdomyosarcoma. PLoS One 2013;8:e68065. [PMID: 23799156 DOI: 10.1371/journal.pone.0068065] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
130 Beitner-johnson D, Seta K, Yuan Y, Kim H, Rust R, Conrad P, Kobayashi S, Millhorn D. Identification of hypoxia-responsive genes in a dopaminergic cell line by subtractive cDNA libraries and microarray analysis. Parkinsonism & Related Disorders 2001;7:273-81. [DOI: 10.1016/s1353-8020(00)00070-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
131 Jacobs JFM, Coulie PG, Figdor CG, Adema GJ, de Vries IJM, Hoogerbrugge PM. Targets for active immunotherapy against pediatric solid tumors. Cancer Immunol Immunother 2009;58:831-41. [DOI: 10.1007/s00262-008-0619-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
132 Péault B, Rudnicki M, Torrente Y, Cossu G, Tremblay JP, Partridge T, Gussoni E, Kunkel LM, Huard J. Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Mol Ther 2007;15:867-77. [PMID: 17387336 DOI: 10.1038/mt.sj.6300145] [Cited by in Crossref: 414] [Cited by in F6Publishing: 379] [Article Influence: 27.6] [Reference Citation Analysis]
133 Martins AS, Olmos D, Missiaglia E, Shipley J. Targeting the insulin-like growth factor pathway in rhabdomyosarcomas: rationale and future perspectives. Sarcoma 2011;2011:209736. [PMID: 21437217 DOI: 10.1155/2011/209736] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
134 Relaix F, Rocancourt D, Mansouri A, Buckingham M. Divergent functions of murine Pax3 and Pax7 in limb muscle development. Genes Dev 2004;18:1088-105. [PMID: 15132998 DOI: 10.1101/gad.301004] [Cited by in Crossref: 209] [Cited by in F6Publishing: 198] [Article Influence: 11.6] [Reference Citation Analysis]
135 Parker MH, Seale P, Rudnicki MA. Looking back to the embryo: defining transcriptional networks in adult myogenesis. Nat Rev Genet 2003;4:497-507. [PMID: 12838342 DOI: 10.1038/nrg1109] [Cited by in Crossref: 231] [Cited by in F6Publishing: 236] [Article Influence: 12.2] [Reference Citation Analysis]
136 Schaaf GJ, Ruijter JM, van Ruissen F, Zwijnenburg DA, Waaijer R, Valentijn LJ, Benit-Deekman J, van Kampen AH, Baas F, Kool M. Full transcriptome analysis of rhabdomyosarcoma, normal, and fetal skeletal muscle: statistical comparison of multiple SAGE libraries. FASEB J 2005;19:404-6. [PMID: 15629888 DOI: 10.1096/fj.04-2104fje] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 2.1] [Reference Citation Analysis]
137 Feng X, Jiang Y, Meltzer P, Yen PM. Thyroid Hormone Regulation of Hepatic Genes in Vivo Detected by Complementary DNA Microarray. Molecular Endocrinology 2000;14:947-55. [DOI: 10.1210/mend.14.7.0470] [Cited by in Crossref: 168] [Cited by in F6Publishing: 172] [Article Influence: 7.6] [Reference Citation Analysis]
138 Skapek SX, Ferrari A, Gupta AA, Lupo PJ, Butler E, Shipley J, Barr FG, Hawkins DS. Rhabdomyosarcoma. Nat Rev Dis Primers. 2019;5:1. [PMID: 30617281 DOI: 10.1038/s41572-018-0051-2] [Cited by in Crossref: 164] [Cited by in F6Publishing: 118] [Article Influence: 54.7] [Reference Citation Analysis]
139 De Bortoli M, Castellino RC, Skapura DG, Shen JJ, Su JM, Russell HV, Hicks MJ, Man T, Kim JY. Patched haploinsufficient mouse rhabdomyosarcoma overexpress secreted phosphoprotein 1 and matrix metalloproteinases. European Journal of Cancer 2007;43:1308-17. [DOI: 10.1016/j.ejca.2007.02.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
140 Skubitz KM, D'Adamo DR. Sarcoma. Mayo Clin Proc 2007;82:1409-32. [PMID: 17976362 DOI: 10.4065/82.11.1409] [Cited by in Crossref: 182] [Cited by in F6Publishing: 150] [Article Influence: 12.1] [Reference Citation Analysis]
141 Güllü G, Karabulut S, Akkiprik M. Functional roles and clinical values of insulin-like growth factor-binding protein-5 in different types of cancers. Chin J Cancer 2012;31:266-80. [PMID: 22313597 DOI: 10.5732/cjc.011.10405] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 3.9] [Reference Citation Analysis]
142 Collins CA, Gnocchi VF, White RB, Boldrin L, Perez-Ruiz A, Relaix F, Morgan JE, Zammit PS. Integrated functions of Pax3 and Pax7 in the regulation of proliferation, cell size and myogenic differentiation. PLoS One 2009;4:e4475. [PMID: 19221588 DOI: 10.1371/journal.pone.0004475] [Cited by in Crossref: 82] [Cited by in F6Publishing: 78] [Article Influence: 6.3] [Reference Citation Analysis]
143 McCoy EL, Kawakami K, Ford HL, Coletta RD. Expression of Six1 homeobox gene during development of the mouse submandibular salivary gland. Oral Dis 2009;15:407-13. [PMID: 19371398 DOI: 10.1111/j.1601-0825.2009.01560.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
144 Parham DM. Pathologic classification of rhabdomyosarcomas and correlations with molecular studies. Mod Pathol 2001;14:506-14. [PMID: 11353062 DOI: 10.1038/modpathol.3880339] [Cited by in Crossref: 149] [Cited by in F6Publishing: 108] [Article Influence: 7.1] [Reference Citation Analysis]
145 Linger RM, Keating AK, Earp HS, Graham DK. TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer. Adv Cancer Res. 2008;100:35-83. [PMID: 18620092 DOI: 10.1016/s0065-230x(08)00002-x] [Cited by in Crossref: 419] [Cited by in F6Publishing: 292] [Article Influence: 29.9] [Reference Citation Analysis]
146 Bach LA, Fu P, Yang Z. Insulin-like growth factor-binding protein-6 and cancer. Clin Sci (Lond) 2013;124:215-29. [PMID: 23126425 DOI: 10.1042/CS20120343] [Cited by in Crossref: 45] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
147 Tomescu O, Barr FG. Chromosomal translocations in sarcomas: prospects for therapy. Trends in Molecular Medicine 2001;7:554-9. [DOI: 10.1016/s1471-4914(01)02244-4] [Cited by in Crossref: 33] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
148 Kuang S, Chargé SB, Seale P, Huh M, Rudnicki MA. Distinct roles for Pax7 and Pax3 in adult regenerative myogenesis. J Cell Biol 2006;172:103-13. [PMID: 16391000 DOI: 10.1083/jcb.200508001] [Cited by in Crossref: 319] [Cited by in F6Publishing: 306] [Article Influence: 19.9] [Reference Citation Analysis]
149 Fleischmann A, Jochum W, Eferl R, Witowsky J, Wagner EF. Rhabdomyosarcoma development in mice lacking Trp53 and Fos. Cancer Cell 2003;4:477-82. [DOI: 10.1016/s1535-6108(03)00280-0] [Cited by in Crossref: 48] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
150 Bharathy N, Suriyamurthy S, Rao VK, Ow JR, Lim HJ, Chakraborty P, Vasudevan M, Dhamne CA, Chang KT, Min VL, Kundu TK, Taneja R. P/CAF mediates PAX3-FOXO1-dependent oncogenesis in alveolar rhabdomyosarcoma. J Pathol 2016;240:269-81. [PMID: 27453350 DOI: 10.1002/path.4773] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
151 Garcia CB, Shaffer CM, Alfaro MP, Smith AL, Sun J, Zhao Z, Young PP, VanSaun MN, Eid JE. Reprogramming of mesenchymal stem cells by the synovial sarcoma-associated oncogene SYT-SSX2. Oncogene 2012;31:2323-34. [PMID: 21996728 DOI: 10.1038/onc.2011.418] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 4.4] [Reference Citation Analysis]
152 Heath LS, Ramakrishnan N, Sederoff RR, Whetten RW, Chevone BI, Struble CA, Jouenne VY, Chen D, van Zyl L, Grene R. Studying the functional genomics of stress responses in loblolly pine with the Expresso microarray experiment management system. Comp Funct Genomics 2002;3:226-43. [PMID: 18628855 DOI: 10.1002/cfg.169] [Cited by in Crossref: 41] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
153 Hron AJ, Asakura A. An Examination of the Role of Transcriptional and Posttranscriptional Regulation in Rhabdomyosarcoma. Stem Cells Int 2017;2017:2480375. [PMID: 28638414 DOI: 10.1155/2017/2480375] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
154 Sather S, Kenyon KD, Lefkowitz JB, Liang X, Varnum BC, Henson PM, Graham DK. A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation. Blood 2007;109:1026-33. [PMID: 17047157 DOI: 10.1182/blood-2006-05-021634] [Cited by in Crossref: 195] [Cited by in F6Publishing: 201] [Article Influence: 12.2] [Reference Citation Analysis]
155 Tomescu O, Xia SJ, Strezlecki D, Bennicelli JL, Ginsberg J, Pawel B, Barr FG. Inducible short-term and stable long-term cell culture systems reveal that the PAX3-FKHR fusion oncoprotein regulates CXCR4, PAX3, and PAX7 expression. Lab Invest 2004;84:1060-70. [PMID: 15184910 DOI: 10.1038/labinvest.3700125] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 2.8] [Reference Citation Analysis]
156 Kendall GC, Watson S, Xu L, LaVigne CA, Murchison W, Rakheja D, Skapek SX, Tirode F, Delattre O, Amatruda JF. PAX3-FOXO1 transgenic zebrafish models identify HES3 as a mediator of rhabdomyosarcoma tumorigenesis. Elife 2018;7:e33800. [PMID: 29869612 DOI: 10.7554/eLife.33800] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
157 Adachi T, Komiyama M, Ono Y, Koh KB, Sakurai K, Shibayama T, Kato M, Yoshikawa T, Seki N, Iguchi T, Mori C. Toxicogenomic effects of neonatal exposure to diethylstilbestrol on mouse testicular gene expression in the long term: a study using cDNA microarray analysis. Mol Reprod Dev 2002;63:17-23. [PMID: 12211056 DOI: 10.1002/mrd.10178] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
158 Koo J, Sohn I, Kim S, Lee JW. Structured polychotomous machine diagnosis of multiple cancer types using gene expression. Bioinformatics 2006;22:950-8. [DOI: 10.1093/bioinformatics/btl029] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
159 Xie Z, Tang Y, Su X, Cao J, Zhang Y, Li H. PAX3-FOXO1 escapes miR-495 regulation during muscle differentiation. RNA Biol 2019;16:144-53. [PMID: 30593263 DOI: 10.1080/15476286.2018.1564464] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
160 McCoy EL, Iwanaga R, Jedlicka P, Abbey NS, Chodosh LA, Heichman KA, Welm AL, Ford HL. Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition. J Clin Invest 2009;119:2663-77. [PMID: 19726883 DOI: 10.1172/JCI37691] [Cited by in Crossref: 123] [Cited by in F6Publishing: 81] [Article Influence: 9.5] [Reference Citation Analysis]
161 Scuoppo C, Riess I, Schmitt-Ney M, Allegra P, Forni PE, Bersani F, Taulli R, Accornero P, Crepaldi T, Ponzetto C. The oncogenic transcription factor PAX3-FKHR can convert fibroblasts into contractile myotubes. Exp Cell Res 2007;313:2308-17. [PMID: 17490646 DOI: 10.1016/j.yexcr.2007.02.037] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
162 Napoli C, de Nigris F, Welch JS, Calara FB, Stuart RO, Glass CK, Palinski W. Maternal Hypercholesterolemia During Pregnancy Promotes Early Atherogenesis in LDL Receptor-Deficient Mice and Alters Aortic Gene Expression Determined by Microarray. Circulation 2002;105:1360-7. [DOI: 10.1161/01.cir.0000013090.96919.fa] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
163 Lagha M, Mayeuf-Louchart A, Chang T, Montarras D, Rocancourt D, Zalc A, Kormish J, Zaret KS, Buckingham ME, Relaix F. Itm2a is a Pax3 target gene, expressed at sites of skeletal muscle formation in vivo. PLoS One 2013;8:e63143. [PMID: 23650549 DOI: 10.1371/journal.pone.0063143] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
164 Kasiappan R, Jutooru I, Mohankumar K, Karki K, Lacey A, Safe S. Reactive Oxygen Species (ROS)-Inducing Triterpenoid Inhibits Rhabdomyosarcoma Cell and Tumor Growth through Targeting Sp Transcription Factors. Mol Cancer Res 2019;17:794-805. [PMID: 30610105 DOI: 10.1158/1541-7786.MCR-18-1071] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
165 Gripp KW, Scott CI, Nicholson L, Mcdonald-mcginn DM, Ozeran JD, Jones MC, Lin AE, Zackai EH. Five additional Costello syndrome patients with rhabdomyosarcoma: Proposal for a tumor screening protocol: Rhabdomyosarcoma in Costello Syndrome. Am J Med Genet 2002;108:80-7. [DOI: 10.1002/ajmg.10241] [Cited by in Crossref: 106] [Cited by in F6Publishing: 87] [Article Influence: 5.3] [Reference Citation Analysis]
166 Zhang L, Wang C. Identification of a new class of PAX3-FKHR target promoters: a role of the Pax3 paired box DNA binding domain. Oncogene 2007;26:1595-605. [PMID: 16964289 DOI: 10.1038/sj.onc.1209958] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
167 Cooper CS. Applications of microarray technology in breast cancer research. Breast Cancer Res 2001;3:158-75. [PMID: 11305951 DOI: 10.1186/bcr291] [Cited by in Crossref: 44] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
168 Lannon CL, Sorensen PH. ETV6–NTRK3: a chimeric protein tyrosine kinase with transformation activity in multiple cell lineages. Seminars in Cancer Biology 2005;15:215-23. [DOI: 10.1016/j.semcancer.2005.01.003] [Cited by in Crossref: 120] [Cited by in F6Publishing: 97] [Article Influence: 7.1] [Reference Citation Analysis]
169 Pressey JG, Pressey CS, Robinson G, Herring R, Wilson L, Kelly DR, Kim H. 2D-difference gel electrophoretic proteomic analysis of a cell culture model of alveolar rhabdomyosarcoma. J Proteome Res 2011;10:624-36. [PMID: 21110518 DOI: 10.1021/pr1008493] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
170 Choi YM, Choi IS, Lee SM, Hwang DY, Choi YW, Park YH. Transcriptome analysis of the effects of gomisin a on the recovery of carbon tetrachloride-induced damage in rat liver. Lab Anim Res 2011;27:161-9. [PMID: 21826177 DOI: 10.5625/lar.2011.27.2.161] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
171 Calhabeu F, Hayashi S, Morgan JE, Relaix F, Zammit PS. Alveolar rhabdomyosarcoma-associated proteins PAX3/FOXO1A and PAX7/FOXO1A suppress the transcriptional activity of MyoD-target genes in muscle stem cells. Oncogene 2013;32:651-62. [DOI: 10.1038/onc.2012.73] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 4.8] [Reference Citation Analysis]
172 Soleimani VD, Yin H, Jahani-Asl A, Ming H, Kockx CE, van Ijcken WF, Grosveld F, Rudnicki MA. Snail regulates MyoD binding-site occupancy to direct enhancer switching and differentiation-specific transcription in myogenesis. Mol Cell 2012;47:457-68. [PMID: 22771117 DOI: 10.1016/j.molcel.2012.05.046] [Cited by in Crossref: 122] [Cited by in F6Publishing: 117] [Article Influence: 12.2] [Reference Citation Analysis]
173 Tanaka TS, Jaradat SA, Lim MK, Kargul GJ, Wang X, Grahovac MJ, Pantano S, Sano Y, Piao Y, Nagaraja R, Doi H, Wood WH 3rd, Becker KG, Ko MS. Genome-wide expression profiling of mid-gestation placenta and embryo using a 15,000 mouse developmental cDNA microarray. Proc Natl Acad Sci U S A 2000;97:9127-32. [PMID: 10922068 DOI: 10.1073/pnas.97.16.9127] [Cited by in Crossref: 270] [Cited by in F6Publishing: 282] [Article Influence: 12.3] [Reference Citation Analysis]
174 Huelse JM, Fridlyand DM, Earp S, DeRyckere D, Graham DK. MERTK in cancer therapy: Targeting the receptor tyrosine kinase in tumor cells and the immune system. Pharmacol Ther 2020;213:107577. [PMID: 32417270 DOI: 10.1016/j.pharmthera.2020.107577] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
175 Wang C. Childhood rhabdomyosarcoma: recent advances and prospective views. J Dent Res 2012;91:341-50. [PMID: 21917598 DOI: 10.1177/0022034511421490] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
176 Lobenhofer EK, Bushel PR, Afshari CA, Hamadeh HK. Progress in the application of DNA microarrays. Environ Health Perspect 2001;109:881-91. [PMID: 11673116 DOI: 10.1289/ehp.01109881] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 2.0] [Reference Citation Analysis]
177 De Craene B, van Roy F, Berx G. Unraveling signalling cascades for the Snail family of transcription factors. Cell Signal 2005;17:535-47. [PMID: 15683729 DOI: 10.1016/j.cellsig.2004.10.011] [Cited by in Crossref: 159] [Cited by in F6Publishing: 147] [Article Influence: 9.4] [Reference Citation Analysis]
178 Gerber JK, Richter T, Kremmer E, Adamski J, Höfler H, Balling R, Peters H. Progressive loss of PAX9 expression correlates with increasing malignancy of dysplastic and cancerous epithelium of the human oesophagus. J Pathol 2002;197:293-7. [PMID: 12115874 DOI: 10.1002/path.1115] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 2.3] [Reference Citation Analysis]
179 Greer EL, Brunet A. FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene. 2005;24:7410-7425. [PMID: 16288288 DOI: 10.1038/sj.onc.1209086] [Cited by in Crossref: 879] [Cited by in F6Publishing: 858] [Article Influence: 51.7] [Reference Citation Analysis]
180 Cao L, Yu Y, Bilke S, Walker RL, Mayeenuddin LH, Azorsa DO, Yang F, Pineda M, Helman LJ, Meltzer PS. Genome-wide identification of PAX3-FKHR binding sites in rhabdomyosarcoma reveals candidate target genes important for development and cancer. Cancer Res 2010;70:6497-508. [PMID: 20663909 DOI: 10.1158/0008-5472.CAN-10-0582] [Cited by in Crossref: 155] [Cited by in F6Publishing: 103] [Article Influence: 12.9] [Reference Citation Analysis]
181 Marques JG, Gryder BE, Pavlovic B, Chung Y, Ngo QA, Frommelt F, Gstaiger M, Song Y, Benischke K, Laubscher D, Wachtel M, Khan J, Schäfer BW. NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency. Elife 2020;9:e54993. [PMID: 32744500 DOI: 10.7554/eLife.54993] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
182 Skubitz KM, Skubitz APN. Role of gene expression arrays in sarcomas. Curr Oncol Rep 2004;6:309-14. [DOI: 10.1007/s11912-004-0041-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
183 Nedea EA, Delaney TF. Sarcoma and Skin Radiation Oncology. Hematology/Oncology Clinics of North America 2006;20:401-29. [DOI: 10.1016/j.hoc.2006.01.017] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
184 Loupe JM, Miller PJ, Bonner BP, Maggi EC, Vijayaraghavan J, Crabtree JS, Taylor CM, Zabaleta J, Hollenbach AD. Comparative transcriptomic analysis reveals the oncogenic fusion protein PAX3-FOXO1 globally alters mRNA and miRNA to enhance myoblast invasion. Oncogenesis 2016;5:e246. [PMID: 27454080 DOI: 10.1038/oncsis.2016.53] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
185 Friedrichs N, Trautmann M, Endl E, Sievers E, Kindler D, Wurst P, Czerwitzki J, Steiner S, Renner M, Penzel R, Koch A, Larsson O, Tanaka S, Kawai A, Schirmacher P, Mechtersheimer G, Wardelmann E, Buettner R, Hartmann W. Phosphatidylinositol-3′-kinase/AKT signaling is essential in synovial sarcoma. Int J Cancer 2011;129:1564-75. [DOI: 10.1002/ijc.25829] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 3.6] [Reference Citation Analysis]
186 Liu T, Lai H, Wu W, Chinn S, Wang PH. Developing a Strategy to Define the Effects of Insulin-Like Growth Factor-1 on Gene Expression Profile in Cardiomyocytes. Circulation Research 2001;88:1231-8. [DOI: 10.1161/hh1201.092036] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
187 Yoshikawa T, Nagasugi Y, Azuma T, Kato M, Sugano S, Hashimoto K, Masuho Y, Muramatsu M, Seki N. Isolation of Novel Mouse Genes Differentially Expressed in Brain Using cDNA Microarray. Biochemical and Biophysical Research Communications 2000;275:532-7. [DOI: 10.1006/bbrc.2000.3330] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 2.3] [Reference Citation Analysis]
188 Saal LH, Troein C, Vallon-Christersson J, Gruvberger S, Borg A, Peterson C. BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data. Genome Biol 2002;3:SOFTWARE0003. [PMID: 12186655 DOI: 10.1186/gb-2002-3-8-software0003] [Cited by in Crossref: 199] [Cited by in F6Publishing: 271] [Article Influence: 10.0] [Reference Citation Analysis]
189 Cripe TP, Mackall CL. Exploiting genetic alterations to design novel therapies for cancer. Hematol Oncol Clin North Am 2001;15:657-75, viii. [PMID: 11676278 DOI: 10.1016/s0889-8588(05)70241-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
190 Zhang Y, Wang C. Nephroblastoma overexpressed (NOV/CCN3) gene: a paired-domain-specific PAX3-FKHR transcription target that promotes survival and motility in alveolar rhabdomyosarcoma cells. Oncogene 2011;30:3549-62. [PMID: 21423212 DOI: 10.1038/onc.2011.69] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
191 O'Brien JH, Hernandez-Lagunas L, Artinger KB, Ford HL. MicroRNA-30a regulates zebrafish myogenesis through targeting the transcription factor Six1. J Cell Sci 2014;127:2291-301. [PMID: 24634509 DOI: 10.1242/jcs.143677] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
192 Shern JF, Yohe ME, Khan J. Pediatric Rhabdomyosarcoma. Crit Rev Oncog 2015;20:227-43. [PMID: 26349418 DOI: 10.1615/critrevoncog.2015013800] [Cited by in Crossref: 36] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
193 Mercado GE, Xia SJ, Zhang C, Ahn EH, Gustafson DM, Laé M, Ladanyi M, Barr FG. Identification of PAX3-FKHR-regulated genes differentially expressed between alveolar and embryonal rhabdomyosarcoma: focus on MYCN as a biologically relevant target. Genes Chromosomes Cancer 2008;47:510-20. [PMID: 18335505 DOI: 10.1002/gcc.20554] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 3.6] [Reference Citation Analysis]
194 Clarke PA, te Poele R, Wooster R, Workman P. Gene expression microarray analysis in cancer biology, pharmacology, and drug development: progress and potential22Abbreviations: ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; Cy, Cyanine; DLCL, diffuse large cell lymphoma; dNTPs, deoxyribonucleotides; ESTs, expressed sequence tags; mRNA, messenger RNA; NHL, non-Hodgkin’s lymphoma; ORF, open reading frame; RT-PCR, reverse transcription-polymerase chain reaction; and 17AAG, 17-allylamino,17-demethoxygeldanamycin. Biochemical Pharmacology 2001;62:1311-36. [DOI: 10.1016/s0006-2952(01)00785-7] [Cited by in Crossref: 134] [Cited by in F6Publishing: 19] [Article Influence: 6.4] [Reference Citation Analysis]
195 Suleiman L, Négrier C, Boukerche H. Protein S: A multifunctional anticoagulant vitamin K-dependent protein at the crossroads of coagulation, inflammation, angiogenesis, and cancer. Crit Rev Oncol Hematol 2013;88:637-54. [PMID: 23958677 DOI: 10.1016/j.critrevonc.2013.07.004] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 4.7] [Reference Citation Analysis]
196 Sebire NJ, Malone M. Myogenin and MyoD1 expression in paediatric rhabdomyosarcomas. J Clin Pathol. 2003;56:412-416. [PMID: 12783965 DOI: 10.1136/jcp.56.6.412] [Cited by in Crossref: 114] [Cited by in F6Publishing: 85] [Article Influence: 6.0] [Reference Citation Analysis]
197 Kiefer J, Alexander A, Farach-Carson MC. Type I collagen-mediated changes in gene expression and function of prostate cancer cells. Cancer Treat Res 2004;118:101-24. [PMID: 15043190 DOI: 10.1007/978-1-4419-9129-4_5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
198 Rikhof B, de Jong S, Suurmeijer AJ, Meijer C, van der Graaf WT. The insulin-like growth factor system and sarcomas. J Pathol 2009;217:469-82. [PMID: 19148905 DOI: 10.1002/path.2499] [Cited by in Crossref: 100] [Cited by in F6Publishing: 94] [Article Influence: 7.7] [Reference Citation Analysis]
199 Bortoluzzi S, Bisognin A, Romualdi C, Danieli GA. Novel genes, possibly relevant for molecular diagnosis or therapy of human rhabdomyosarcoma, detected by genomic expression profiling. Gene 2005;348:65-71. [DOI: 10.1016/j.gene.2004.12.024] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
200 De Pittà C, Tombolan L, Albiero G, Sartori F, Romualdi C, Jurman G, Carli M, Furlanello C, Lanfranchi G, Rosolen A. Gene expression profiling identifies potential relevant genes in alveolar rhabdomyosarcoma pathogenesis and discriminates PAX3-FKHR positive and negative tumors. Int J Cancer 2006;118:2772-81. [PMID: 16381018 DOI: 10.1002/ijc.21698] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 2.4] [Reference Citation Analysis]
201 Allander SV, Illei PB, Chen Y, Antonescu CR, Bittner M, Ladanyi M, Meltzer PS. Expression profiling of synovial sarcoma by cDNA microarrays: association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation. Am J Pathol 2002;161:1587-95. [PMID: 12414507 DOI: 10.1016/S0002-9440(10)64437-9] [Cited by in Crossref: 140] [Cited by in F6Publishing: 47] [Article Influence: 7.0] [Reference Citation Analysis]
202 Olguín HC, Patzlaff NE, Olwin BB. Pax7-FKHR transcriptional activity is enhanced by transcriptionally repressed MyoD. J Cell Biochem 2011;112:1410-7. [PMID: 21321994 DOI: 10.1002/jcb.23057] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
203 Cummings CA, Relman DA. Using DNA microarrays to study host-microbe interactions. Emerg Infect Dis 2000;6:513-25. [PMID: 10998383 DOI: 10.3201/eid0605.000511] [Cited by in Crossref: 147] [Cited by in F6Publishing: 117] [Article Influence: 6.7] [Reference Citation Analysis]
204 Finckenstein FG, Davicioni E, Osborn KG, Cavenee WK, Arden KC, Anderson MJ. Transgenic mice expressing PAX3-FKHR have multiple defects in muscle development, including ectopic skeletal myogenesis in the developing neural tube. Transgenic Res 2006;15:595-614. [PMID: 16952014 DOI: 10.1007/s11248-006-9011-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
205 Chadalapaka G, Jutooru I, Sreevalsan S, Pathi S, Kim K, Chen C, Crose L, Linardic C, Safe S. Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors. Int J Cancer 2013;132:795-806. [PMID: 22815231 DOI: 10.1002/ijc.27730] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
206 Shim J, Sohn I, Kim S, Lee JW, Green PE, Hwang C. Selecting marker genes for cancer classification using supervised weighted kernel clustering and the support vector machine. Computational Statistics & Data Analysis 2009;53:1736-42. [DOI: 10.1016/j.csda.2008.04.028] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
207 Eid JE, Garcia CB. Reprogramming of mesenchymal stem cells by oncogenes. Semin Cancer Biol 2015;32:18-31. [PMID: 24938913 DOI: 10.1016/j.semcancer.2014.05.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
208 Hu Q, Zhu L, Li Y, Zhou J, Xu J. ACTA1 is inhibited by PAX3-FOXO1 through RhoA-MKL1-SRF signaling pathway and impairs cell proliferation, migration and tumor growth in Alveolar Rhabdomyosarcoma. Cell Biosci 2021;11:25. [PMID: 33509264 DOI: 10.1186/s13578-021-00534-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]